Latest filing published 11 Feb 2026 for SpyGlass Pharma, Inc., €1.6M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +2.6%Entry US$27.50 · Close 22 Oct 2026 US$28.22
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Bilal Arshad Khan: trading record in brief
Bilal Arshad Khan appears in our data through filings on SpyGlass Pharma, Inc. shares, published by SEC (Form 4). Activity is concentrated on a single trading day, 9 February 2026, with 2 filings.
Purchases make up the whole of the open-market record (2 purchases, €1.8M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The newest entry dates from 11 February 2026: an open-market purchase of €1.6M, in SpyGlass Pharma, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Bilal Arshad Khan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 115,000 shares@ US$16.0085.2% of flowCommon StockSEC:0002108044-26-000006:1Canonical exit: 10 May 2026 (T+90)
- 20,000 shares@ US$16.00100.0% of flowCommon StockSEC:0002108044-26-000006:0Canonical exit: 10 May 2026 (T+90)
2 of 2 declarations
